| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 07/11/2000 | US6087147 Nucleic acid encoding maltopentaose-producing alpha-amylase having amino acid sequence derived from pseudomonas species but modified by amino acid replacement to reduce degrading activity; does not degrade product to maltotriose or maltose |
| 07/11/2000 | US6087146 Recombinant thermostable enzyme for converting maltose into trehalose |
| 07/11/2000 | US6087145 Esterase gene and its use |
| 07/11/2000 | US6087144 Mammalian enzymatic protein receptor; for the activation of cell differentiation and propagation; for screening modulators or receptor activity |
| 07/11/2000 | US6087142 Valyl tRNA synthetase from streptococcus pneumoniae |
| 07/11/2000 | US6087132 Preparing deoxyribonucleotide; incubation of enzymatic polypeptide with nucleic acids, enzymatic polypeptide catalyzes the reduction of the ribosyl group of the nucleic acids to form deoxyribonucleic acid, recovering |
| 07/11/2000 | US6087127 Nucleotide sequence which codes a viral disease polypeptide; for the development of vaccines for prevention of viral infection |
| 07/11/2000 | US6087126 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| 07/11/2000 | US6087117 Murine immunoglobulin which binds to mamalian tumor protein; for genetic testing of cancer senesitivity, diagnosis, and treatment |
| 07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 07/11/2000 | US6087106 Nucleic acids conferring and inducible resistance to glycopeptides particularly in gram-positive bacteria |
| 07/11/2000 | US6086895 Treatment with proteins and polypeptides |
| 07/11/2000 | US6086894 Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/11/2000 | US6086893 Helicobacter lactoferrin receptor |
| 07/11/2000 | US6086867 By contacting the cell with a soluble polypeptide comprising the amino acid sequence of the extracellular domain of the transforming growth factor-beta (tgf-b) type iii receptor protein or mammalian dna encoding it |
| 07/11/2000 | CA2082948C Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 07/11/2000 | CA2079912C Hepatitis c virus epitopes |
| 07/11/2000 | CA2062281C Biotechnological process for the production of s-(+)-2,2-dimethylcyclopropanecarboxamide |
| 07/11/2000 | CA2042425C Biocatalytic process for the production of l-(-)-carnitine from crotonobetaine and strains of proteeae for use in said process |
| 07/11/2000 | CA2033069C Saf polypeptide, gene, promoter and use for expression in streptomyces |
| 07/11/2000 | CA2024279C Recombinant c-terminal -amidating enzyme of human thyroid origin |
| 07/11/2000 | CA2012740C A monoclonal antibody recognizing c-terminus of anp |
| 07/11/2000 | CA1341050C Neurite growth regulatory factors |
| 07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
| 07/06/2000 | WO2000039322A1 Methods for producing polypeptides in aspergillus mutant cells |
| 07/06/2000 | WO2000039321A1 POLYSACCHARIDES CONTAINING α-1,4-GLUCAN CHAINS AND METHOD FOR PRODUCING SAME |
| 07/06/2000 | WO2000039282A1 Production of proteins |
| 07/06/2000 | WO2000039276A2 Microbial transformation method for the preparation of an epothilone |
| 07/06/2000 | WO2000039165A1 Serine protease inhibitor |
| 07/06/2000 | WO2000039163A1 Modification of interferon alpha production |
| 07/06/2000 | WO2000039035A1 Process for the treatment of waste water containing heavy metals |
| 07/06/2000 | WO2000038732A1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/06/2000 | WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | WO2000020612A3 Therapeutically active proteins in plants |
| 07/06/2000 | WO2000015827A3 Bacterial strains for the production of 2-keto-l-gulonic acid |
| 07/06/2000 | WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof |
| 07/06/2000 | WO2000009727A8 Dna shuffling to produce herbicide selective crops |
| 07/06/2000 | WO1999054448A3 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue |
| 07/06/2000 | DE19860376A1 Alpha-1,4 Glucanketten enthaltende Polysaccharide sowie Verfahren zu ihrer Herstellung Alpha-1,4 glucan-containing polysaccharides as well as processes for their preparation |
| 07/06/2000 | CA2356834A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | CA2356424A1 Serine protease inhibitor |
| 07/06/2000 | CA2356360A1 Microbial transformation method for the preparation of an epothilone |
| 07/05/2000 | EP1016724A2 Plasmids expressing the trigger factors GroEL or GroES |
| 07/05/2000 | EP1016722A1 Method of dwarfing plants |
| 07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
| 07/05/2000 | EP1016710A2 Method for producing L-amino acids |
| 07/05/2000 | EP1016709A1 Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same |
| 07/05/2000 | EP1016708A1 Yeast extract composition, yeast for obtaining the same, and process for producing yeast extract composition |
| 07/05/2000 | EP1016633A1 Process for the treatment of waste water containing heavy metals |
| 07/05/2000 | EP1015621A2 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 07/05/2000 | EP1015612A1 Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae |
| 07/05/2000 | EP1015594A1 Attenuated respiratory syncytial viruses |
| 07/05/2000 | EP1015592A1 $i(BACILLUS THURINGIENSIS) CRYET33 AND CRYET34 COMPOSITIONS AND USES THEREFOR |
| 07/05/2000 | EP1015565A2 Biological systems for manufacture of polyhydroxylalkanoate polymers containing 4-hydroxyacids |
| 07/05/2000 | EP1015563A1 Transaminases and aminotransferases |
| 07/05/2000 | EP1015477A1 32 human secreted proteins |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP1015038A1 Methods for the detection, treatment, and prevention of neurodegeneration |
| 07/05/2000 | EP0805876B1 Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia |
| 07/05/2000 | EP0702691B1 New thiodepsipeptide isolated from a marine actinomycete |
| 07/05/2000 | EP0619839B1 Novel polypeptides for promoting cell attachment |
| 07/05/2000 | EP0577752B1 Human pf4a receptors and their use |
| 07/05/2000 | CN1259167A Agrobacterium mediated transformation of moulds, in particular those belonging to the genus aspergillus |
| 07/04/2000 | US6084086 Polynucleotide which codes for a polypeptide from the two component signal transduction system of staphylococcus aureus; for diagnosis of bacterial infections; for bactericides, bacteriostats |
| 07/04/2000 | US6084085 Inducing resistance to tumor growth with soluble IGF-1 receptor |
| 07/04/2000 | US6083928 Applying topically to skin composition containing lipopolysaccharide extracted from klebsiella pneumoniae strain |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083746 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083745 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083743 Dna and amino acid sequences; for diagnosis and treatment of infections including otitis media, epiglottitis, pneumonia, and tracheobronchitis; for immunogenic compositions/vaccines |
| 07/04/2000 | US6083734 Recombinant xylanase, the preparation and use of thereof |
| 07/04/2000 | US6083720 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 07/04/2000 | US6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis |
| 07/04/2000 | US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease |
| 07/04/2000 | US6083712 Biotechnological method of producing biotin |
| 07/04/2000 | US6083711 Proteases compositions capable of binding to said site, and methods of use thereof |
| 07/04/2000 | US6083686 A gene for heat resistant enzyme; for the simple and efficient production of heat resistant enzyme in bacteria |
| 07/04/2000 | US6083540 Process for stabilizing proteins in an acidic environment with a high-ester pectin |
| 07/04/2000 | US6083511 Isolated equine herpesvirus-4 (ehv-4) or gh or gc polypeptides and antigenic fragments; vaccine for the protection of horses against ehv-4 infection |
| 07/04/2000 | US6083499 Pesticidal toxins |
| 07/04/2000 | CA2103021C Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 07/04/2000 | CA1341042C Y, & t cell receptor and methods for detection |
| 06/30/2000 | CA2291895A1 Method for producing l-amino acid |
| 06/29/2000 | WO2000037676A1 Method of sequence identification |
| 06/29/2000 | WO2000037671A2 Improved in vivo production of cephalosporins |
| 06/29/2000 | WO2000037669A2 Non-continuous process for the production of vitamin b12 |
| 06/29/2000 | WO2000037667A1 Method for producing ascorbic acid intermediates |
| 06/29/2000 | WO2000037666A1 Process for producing (r)-2-hydroxy-1-phenoxypropane derivative |
| 06/29/2000 | WO2000037658A2 Chemically modified enzymes with multiple charged variants |
| 06/29/2000 | WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth |
| 06/29/2000 | WO2000037627A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 06/29/2000 | WO2000037626A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 06/29/2000 | WO2000037625A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 06/29/2000 | WO2000037624A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 06/29/2000 | WO2000037621A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 06/29/2000 | WO2000037614A2 Variants of egiii-like cellulase and compositions thereof |
| 06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
| 06/29/2000 | WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 06/29/2000 | WO2000037599A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
| 06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |